Ligand validation:4CZ0

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4CZ0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CZ0_NAG_C_420	22%	67%	0.226	0.844	0.5	0.75	-	-	1	1	100%	0.9333
4CZ0_NAG_A_420	13%	54%	0.3	0.843	0.47	1.3	-	1	0	1	100%	0.9333
4CZ0_NAG_C_401	12%	59%	0.252	0.783	0.54	1.01	-	-	0	1	100%	0.9333
4CZ0_NAG_A_401	11%	67%	0.279	0.8	0.5	0.77	-	-	0	0	100%	0.9333
4CZ0_NAG_E_420	7%	55%	0.284	0.74	0.47	1.23	-	1	0	1	100%	0.9333
4CZ0_NAG_F_211	4%	62%	0.362	0.75	0.47	0.98	-	1	0	1	100%	0.9333
4CZ0_NAG_E_401	3%	40%	0.349	0.701	0.51	1.79	-	4	1	1	100%	0.9333
4QY2_NAG_J_601	77%	75%	0.099	0.937	0.44	0.55	-	-	0	0	100%	0.9333
4QY1_NAG_D_601	77%	85%	0.109	0.947	0.3	0.44	-	-	1	0	100%	0.9333
4WSX_NAG_K_401	76%	21%	0.097	0.933	0.46	2.78	-	3	0	0	100%	0.9333
4QY0_NAG_J_601	68%	79%	0.132	0.945	0.35	0.51	-	-	0	0	100%	0.9333
6TWV_NAG_J_201	68%	48%	0.115	0.925	0.33	1.66	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333
5U7O_NAG_B_704	100%	88%	0.024	0.989	0.23	0.44	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.